Statistics of Everolimus (EVE) plus exemestane (EXE) in elderly patients (pts) with hormone receptor-positive (HR+), human epidermal growth receptor-2 negative (HER2-) advanced breast cancer (ABC) progressing on prior nonsteroidal aromatase inhibitors (NSAIs) : Insights on safety from BALLET (CRAD001YIC04)

Created with Highcharts 9.2.2Number of downloadsChart context menuNumber of downloadsGenerated via ORBi - 23/05/2025
Loading...
Created with Highcharts 9.2.2Number of downloadsChart context menuNumber of downloads by countryGenerated via ORBi - 23/05/2025
Loading...
Created with Highcharts 9.2.2Number of viewsChart context menuNumber of viewsGenerated via ORBi - 23/05/2025
Loading...
Created with Highcharts 9.2.2Number of viewsChart context menuNumber of views by countryGenerated via ORBi - 23/05/2025
Loading...
Created with Highcharts 9.2.2Chart context menuOrigin of ORBi's visitorsGenerated via ORBi - 23/05/2025
Loading...
Contact ORBi